Derm.city

01/13/2025

In a study published in RMD Open (2024; 10:e004314), researchers shed new light on the progression from psoriasis (PsO) to psoriatic arthritis (PsA), focusing on the critical “subclinical PsA” stage https://www.derm.city/post/vender-on-psoriasis-key-findings-of-a-study-analysed-in-the-december-2024-issue-of-the-chronicle-o

In each issue of The Chronicle of Skin & Allergy, Dr. Ronald B. Vender of Hamilton, Ont. comments on recent papers related to psoriasis. Dr. Vender has more than 30 years of clinical practice experience and more than 100 clinical trials in psoriasis.Following is an excerpt from his most recent colum...

12/23/2024

The writers and editorial team at Derm.city would like to wish our readers and their families the very best this holiday season. Derm.city will return Jan. 13, 2025, for another year as the website Where Dermatology Lives.

The writers and editorial team at Derm.city would like to wish our readers and their families the very best this holiday season.Thank you for another great year of support. Your readership allows us to bring the latest dermatology news and videos to you every week.Derm.city will return Jan. 13, 2025...

12/20/2024

Derm.city requests our readers' assistance in ranking the most significant innovations in dermatology over the last 30 years. Please follow the link to complete the survey https://www.derm.city/post/survey-invitation-top-dermatology-innovations-of-the-past-30-years

Derm.city requests our readers' assistance in ranking the most significant innovations in dermatology over the last 30 years.The Chronicle of Skin & Allergy, Canada’s premier news journal of dermatology, is celebrating its 30th anniversary this year. The publication will showcase these innovations...

12/16/2024

Findings from a systematic review of controlled clinical trials indicate that botulinum toxin A injections, commonly used for dermatologic purposes, may also alleviate symptoms of major depressive disorder https://www.derm.city/post/botulinum-toxin-shows-promise-in-mood-enhancement-study-suggests

A systematic review of controlled clinical trials presented at the American Academy of Dermatology's annual meeting indicates that botulinum toxin A injections, commonly used for dermatologic purposes, may also alleviate symptoms of major depressive disorder (MDD). (A full article examining this rev...

12/13/2024

Findings from a large case-control study show individuals with celiac disease are at elevated risk of developing alopecia areata https://www.derm.city/post/celiac-disease-associated-with-elevated-alopecia-areata-risk

Findings from a large case-control study support a link between alopecia areata and celiac disease.Published online in Journal of the American Academy of Dermatology, this research followed up on an earlier cross-sectional study (Dev K et al: Frequency of cutaneous disorders in patients with celiac....

12/09/2024

New research suggests comorbidities play a role in the sexual dysfunction linked to the use of 5-alpha-reductase inhibitors prescribed for androgenetic alopecia https://www.derm.city/post/aga-study-shows-5-alpha-reductase-inhibitor-tx-and-male-sexual-dysfunction-not-significant-without

Comorbidities play a role in the sexual dysfunction linked to use of 5-alpha-reductase inhibitors prescribed for androgenetic alopecia (AGA). That’s according to research presented at a medical residents and fellows symposium at the annual meeting of the American Academy of Dermatology and publish...

12/06/2024

New findings show ambient temperature and relative humidity are important factors in skin aging, even after controlling for ultraviolet light exposure and patient age https://www.derm.city/post/heat-index-contributes-to-skin-aging

Ambient temperature and relative humidity are important factors in skin aging, even after controlling for ultraviolet (UV) light exposure and patient age.These findings come from a paper published online in the journal Dermatitis.In a press release, the paper’s authors note it is the first epidemi...

12/02/2024

Patients with atopic dermatitis (AD) are more likely to have eating disorders than patients without AD, according to research presented at the annual meeting of the American Academy of Dermatology

Patients with atopic dermatitis (AD) are more likely to have eating disorders than patients without AD, and dermatologists may be in a position to identify this risk at an early stage. That’s according to a research poster presented at the annual meeting of the American Academy of Dermatology and ...

11/29/2024

Study shows significant differences in tumour characteristics among pediatric and adolescent and young adult (AYA) patients with cutaneous melanoma, according to new findings https://www.derm.city/post/variations-in-cutaneous-melanoma-in-young-patients-identified

There are significant differences in tumour characteristics among pediatric and adolescent and young adult (AYA) patients with cutaneous melanoma, according to new findings. Fortunately, trends in incidence rates are decreasing for young patients diagnosed with this form of cancer.These findings com...

11/25/2024

Researchers at NYU Langone Health and its Perlmutter Cancer Center have developed a remote diagnostic tool demonstrating high accuracy in identifying melanoma. This system permits specialists to examine skin lesions remotely using dermoscopy https://www.derm.city/post/remote-telemedicine-tool-highly-accurate-in-melanoma-dx

Researchers at NYU Langone Health and its Perlmutter Cancer Center have developed a remote diagnostic tool, SpotCheck, which demonstrates high accuracy in identifying melanoma. This system permits specialists to examine skin lesions remotely using dermoscopy.In a study published in the Journal of th...

11/22/2024

Registration is open for the first-ever Indigenous Skin Spectrum Global Summit on April 5, 2025, in Montreal. The Summit will highlight the unique dermatologic challenges facing Indigenous populations across the world https://www.derm.city/post/first-annual-indigenous-skin-spectrum-global-summit-to-be-held-in-april

11/18/2024

Researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. These vaccines could significantly enhance the effectiveness of immune checkpoint inhibition treatments https://www.derm.city/post/sars-cov-2-mrna-vaccines-improve-clinical-responses-to-immune-checkpoint-inhibition

In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The findings, particularly relevant for melanoma patients and those with non-small cell lung carcinoma (NSCLC), suggest that these vaccines could significantly enhance the e...

11/16/2024

To enhance care for Indigenous patients, Canadian physicians are encouraged to familiarize themselves with the Non-Insured Health Benefits program, said Dr. Megan MacGillivray during a presentation at the 2024 Indigenous Skin Spectrum Summit https://www.derm.city/post/understanding-the-nihb-to-improve-indigenous-skin-outcomes

To enhance care for Indigenous dermatology patients, Canadian physicians are being encouraged to familiarize themselves with the Non-Insured Health Benefits (NIHB) program, said Dr. Megan MacGillivray during a presentation at the 2024 Indigenous Skin Spectrum Summit. The NIHB is a federal initiative...

11/11/2024

Dr. Patricia Treadwell suggests several ways dermatologists can contribute to dermatologic health equity through medical student and resident education https://www.derm.city/post/strategies-to-enhance-equity-diversity-and-inclusion-in-dermatology

There is a significant discrepancy between population demographics and representation in dermatology resources, and a critical need for greater diversity and inclusion in educational materials and clinical practice. That’s according to Dr. Patricia Treadwell, Professor Emeritus of Dermatology and ...

11/08/2024

The American Academy of Dermatology has announced a new initiative to analyze data on hidradenitis suppurativa to help dermatologists identify and treat patients more effectively https://www.derm.city/post/new-aad-project-to-gather-hs-patient-insights

On Oct. 30, 2024, the American Academy of Dermatology (AAD) announced a new initiative to shed light on hidradenitis suppurativa (HS). In a press release, AAD President Dr. Seemal R. Desai said that patients with HS are often misdiagnosed or undiagnosed for years, which can lead to scarring, pain, a...

11/04/2024

The deadline for submissions to the 2024 Dermatology Resident Essay Competition for Canadian medical residents is Nov. 15, 2024. More details in post. https://www.derm.city/post/deadline-approaching-for-dermatology-resident-essay-competition

11/01/2024

In a presentation from the Great Lakes Immunodermatology Exchange 5.5, Dr. Jennifer Beecker (Ottawa) discusses the use of JAK inhibitors in alopecia areata https://www.derm.city/post/jak-inhibitors-for-alopecia-areata

JAK inhibitors are emerging as effective treatments for alopecia areata, said Ottawa-based dermatologist Dr. Jennifer Beecker during a presentation at the Great Lakes Immunodermatology Exchange (GLIDE) 5.5 webinar in April 2024. Her presentation is covered in detail in an article in the September 20...

10/28/2024

Researchers have created a novel bioelectronic device that uses programmable electrical stimulation to combat Staphylococcus epidermidis, a common bacterium associated with hospital-acquired infections and antibiotic resistance https://www.derm.city/post/bioelectronic-device-effective-against-infections

Researchers from the University of Chicago and the University of California San Diego have created a novel bioelectronic device they say could revolutionize the treatment of bacterial infections without relying on antibiotics. The study, published in the journal Device, demonstrates how programmable...